On the safety of glucosamine sulfate in patients with insulin resistance

On the safety of glucosamine sulfate in patients with insulin resistance

Aim. Insulin resistance, metabolic syndrome and type 2 diabetes mellitus (T2DM) stimulate the development of chronic inflammation and make it difficult to rehabilitate patients with any comorbid pathology. In particular, T2DM impairs cartilage metabolism, leading to osteoarthritis (OA). For the trea...

Full description

Bibliographic Details
Main Authors: Olga A. Gromova, Ivan Iu. Torshin, Aleksandr M. Lila, Anton V. Naumov, Konstantin V. Rudakov
Format: Article
Language:Russian
Published: ZAO "Consilium Medicum" 2019-04-01
Series:Consilium Medicum
Subjects:
osteoarthritis
insulin resistance
glucosamine sulfate
chondroitin sulfate
pharma-safety
Sustaguard Arthro
Chondroguard
Online Access:http://consilium.orscience.ru/en/archive/2019/vol-21-4-2019/on-the-safety-of-glucosamine-sulfate-in-patients-with-insulin-resistance_5477/?element

Internet

http://consilium.orscience.ru/en/archive/2019/vol-21-4-2019/on-the-safety-of-glucosamine-sulfate-in-patients-with-insulin-resistance_5477/?element

Similar Items